General Information of Drug (ID: DM7U8LD)

Drug Name
1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one
Synonyms SCHEMBL3487432; CHEMBL462548
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 294.26
Logarithm of the Partition Coefficient (xlogp) 5.1
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 6
Chemical Identifiers
Formula
C14H15F5O
IUPAC Name
1,1,1,2,2-pentafluoro-8-phenyloctan-3-one
Canonical SMILES
C1=CC=C(C=C1)CCCCCC(=O)C(C(F)(F)F)(F)F
InChI
InChI=1S/C14H15F5O/c15-13(16,14(17,18)19)12(20)10-6-2-5-9-11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10H2
InChIKey
SZHLULFEEMJIQU-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
25059299
TTD ID
D0U2QY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytosolic phospholipase A2 (GIVA cPLA2) TTT1JVS PA24A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes. J Med Chem. 2008 Dec 25;51(24):8027-37.